4. Wagner, A. D., Grothey, A., Andre, T., Dixon, J. G., Wolmark, N., Haller, D. G., Allegra, C. J., de Gramont, A., VanCutsem, E., Alberts, S. R., George, T. J., O'Connell, M. J., Twelves, C., Taieb, J., Saltz, L. B., Blanke, C. D., Francini, E., Kerr, R., Yothers, G., Seitz, J. F., Marsoni, S., Goldberg, R. M., Shi, Q., Sex and adverse events of adjuvant chemotherapy in colon cancer: an analysis of 34,640 patients in the ACCENT database. Journal of the National Cancer Institute, Apr 2021. 113(4):400-407. https://doi.org/10.1093/jnci/djaa124
|
5. Tutt, A. N. J., Garber, J. E., Kaufman, B., Viale, G., Fumagalli, D., Rastogi, P., Gelber, R. D., de Azambuja, E., Fielding, A., BalmaƱa, J., Domchek, S. M., Gelmon, K. A., Hollingsworth, S. J., Korde, L. A., Linderholm, B., Bandos, H., Senkus, E., Suga, J. M., Shao, Z., Pippas, A. W., Nowecki, Z., Huzarski, T., Ganz, P. A., Lucas, P. C., Baker, N., Loibl, S., McConnell, R., Piccart, M., Schmutzler, R., Steger, G. G., Costantino, J. P., Arahmani, A., Wolmark, N., McFadden, E., Karantza, V., Lakhani, S. R., Yothers, G., Campbell, C., Geyer, C. E. Jr; OlympiA Clinical Trial Steering Committee and Investigators, Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer. N Engl J Med, Jun 3, 2021. EPub ahead of print https://doi.org/10.1056/nejmoa2105215
|